We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Dystroglycan Critical for Nervous System Development

By Biotechdaily staff writers
Posted on 04 Jul 2003
Researchers studying structure/function relationships in the nervous system have found that the protein dystroglycan is critical for the formation of myelin sheaths and the development of a normal nervous system.

Dystroglycan is found in Schwann cells, the source of the myelin sheaths that wrap around the axons and allow nervous impulses to move faster and more efficiently along the nerves. More...
Using a genetically engineered line of mice lacking the gene for dystroglycan, investigators from the University of Iowa (Iowa City, USA) found that the specific mutation they had introduced caused progressive nerve damage in the mice. The mice were less coordinated than normal mice, and their sensitivity to heat and pressure was altered. Moreover, nerve impulses traveled more slowly in these mice. At the molecular level, loss of dystroglycan reduced the density of the sodium channels that are critical for normal transmission of nerve impulses. These findings were published in the June 5, 2003, issue of Neuron.

"The slowing in the time it takes for a signal to travel along the nerve is really interesting,” said senior author Dr. Kevin Campbell, professor and interim head of physiology and biophysics and professor of neurology at the University of Iowa. "We think that dystroglycan may play a role in organizing the sodium channels at the nodes and setting up the proper nodal structure for efficient transmission of nerve signals.”




Related Links:
University of Iowa

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Thyroid Test
Anti-Thyroid EIA Test
New
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.